Identification of Biomarkers for the Study of the Diabetic Foot and Evolution. (SCFOOT)
Identification of Biomarkers for the Study of Sarcopenia and Its Evolution in Diabetic Patients.
Sponsor: Esther Soler
This observational or N/A phase trial investigates Diabetes Mellitus and Diabetic Foot and is currently ongoing. Esther Soler leads this study, which shows 4 recorded versions since 2023 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
4 versions recorded-
Apr 2025 — Present [monthly]
Unknown
Status: Not Yet Recruiting → Unknown
-
Sep 2024 — Apr 2025 [monthly]
Not Yet Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Not Yet Recruiting
-
Apr 2023 — Jul 2024 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Esther Soler
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.